The role of TMP21 in trafficking and amyloid-β precursor protein (APP) processing in Alzheimer's disease.
Alzheimer's Disease (AD) is the most common neurodegenerative disorder leading to dementia. A major neuropathological hallmark of AD is the deposition of amyloid-β protein (Aβ) in the form of neuritic plaques. Aβ is formed by the sequential cleavage of amyloid-β precursor protein (APP) by β- and γ -secretase. It was recently suggested that TMP21 is a novel member of the γ-secretase complex which negatively regulates APP cleavage at the γ-site, but does not affect cleavage of APP or Notch at the -site . In vitro knockdown of TMP21 increases Aβ production and AD patients have less TMP21 expressed in their brains, suggesting that a deficiency in TMP21 may exacerbate AD pathology. TMP21 is most commonly known for its role in vesicle trafficking. Here we present the most recent research on TMP21 in relation to AD, including TMP21's roles in the modulation of γ-secretase activity and protein trafficking.
Townsend Family Laboratories, Department of Psychiatry, The University of British Columbia, Vancouver, Canada.
Kelley
K
Bromley-Brits
Weihong
W
Song
D000544:Alzheimer Disease / Q000378:metabolism* / Q000473:pathology; D053829:Amyloid Precursor Protein Secretases / Q000378:metabolism; D016564:Amyloid beta-Protein Precursor / Q000378:metabolism*; D000818:Animals; D001921:Brain / Q000473:pathology; D006801:Humans; D008565:Membrane Proteins / Q000378:metabolism*; D008954:Models, Biological; D029543:Nucleocytoplasmic Transport Proteins; D058225:Plaque, Amyloid / Q000378:metabolism; D021381:Protein Transport / Q000502:physiology
D016564:Amyloid beta-Protein Precursor; D008565:Membrane Proteins; D029543:Nucleocytoplasmic Transport Proteins; C484395:TMED10 protein, human; D053829:Amyloid Precursor Protein Secretases